Table 4

Two-Year Medical Therapy and Relevant Laboratory Findings in Patients With Normal Versus Abnormal MPS

Patients With Normal MPS
(n = 291)
Patients With Abnormal MPS
(n = 73)
p Value
Antiplatelet therapy5388<0.0001
Oral anticoagulants5150.0044
Beta-blocker3192<0.0001
Calcium antagonist29330.60
Nitrates100.88
Statins6096<0.0001
ACE-I/ARB76840.22
Diuretics48620.05
Oral glucose-lowering therapy78710.26
Insulin50550.50
HbA1c, %7.4 ± 1.37.4 ± 1.20.98
Total cholesterol, mmol/l4.5 ± 1.13.6 ± 0.9<0.0001
LDL cholesterol, mmol/l2.4 ± 0.91.7 ± 0.8<0.0001
HDL, mmol/l1.26 ± 0.41.20 ± 0.40.03
Systolic blood pressure, mm Hg131.0 ± 17.0132.0 ± 19.00.93

Values are % or mean ± SD.

ACE-I/ARB = angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; HbA1c = hemoglobin A1c; HDL = high-density lipoprotein; LDL = low-density lipoprotein; MPS = myocardial perfusion single-photon emission computed tomography.

  • p values were calculated with the use of a Mann-Whitney U test for quantitative variables and a chi-square test for qualitative variables.